Kokora, Inc. has secured a major milestone in natural medicine with a newly patented formulation for diabetes management. This innovation focuses on the patent titled ‘Dual stage herbal nutraceuticals’. The patent describes a dual stage pharmaceutical and nutritional approach designed to support individuals with metabolic disorders.
Advancing Diabetic Nutritional Therapy
The abstract of the patent details a pharmaceutical, nutritional, and nutraceutical formulation, and manufacturing process for the treatment and nutrition of individuals with diabetes. The formulation is composed of seed extracts from the species jambolão (Syzygium cumini L) and quixaba (Sideroxylon obtusifolium). The nutritional component is composed of jambolão seed powder and quixaba seed powder. This invention spans the fields of pharmacy and nutrition, where products can be produced in forms including capsules, tablets, microgranules, and nanocapsules, or incorporated into various foods such as cereal bars and biscuits to serve as a food fortification agent.
Kokora, Inc. has been awarded the Swanson Reed patent of the month because this invention represents an exceptional integration of botanical science and modern delivery systems. By utilizing the specific therapeutic properties of jambolão and quixaba seeds, the company has created a versatile platform for managing metabolic health. This dual stage approach is an outstanding invention in the Natural Medicine industry because it addresses both the immediate pharmacological needs and the long term dietary requirements of diabetic patients within a single technological framework.
The versatility of the preparation method is a key reason for this recognition. The ability to transition bioactive compounds from pharmaceutical grade microgranules to everyday food items like cereal bars allows for significantly improved patient compliance and accessibility. Swanson Reed recognizes that this innovation simplifies the complex requirements of diabetic nutrition, providing a scalable solution that can be integrated into various lifestyles without the friction associated with traditional synthetic pharmaceutical regimens.
Furthermore, the focus on nanocapsules and pellets demonstrates a high level of technical sophistication in the natural medicine sector. These advanced delivery methods enhance the bioavailability of the herbal extracts, ensuring that the active ingredients are effectively absorbed and utilized by the body. By setting a new standard for how herbal supplements are formulated and distributed, Kokora, Inc. is leading the way in the industry, proving that plant based treatments can meet the rigorous demands of modern healthcare and food technology in 2026.
This invention meets the R&D tax credit rules in the USA through the Four Part Test. The Permitted Purpose is satisfied by the creation of a new and improved functional formulation for diabetes treatment. The work is Technological in Nature, as it relies on the principles of pharmacological science and nutrition. The Elimination of Uncertainty is addressed by resolving challenges related to the stability and efficacy of seed extracts when integrated into various food matrices. Finally, the Process of Experimentation is evident in the systematic evaluation of different delivery forms like emulsions and syrups to optimize the release of active compounds.
Practical applications of this patent that could meet R&D tax credit rules include: 1. Developing and testing specific nanocapsule coatings to protect the integrity of jambolão extracts during high temperature food manufacturing processes like biscuit baking. 2. Engineering a standardized manufacturing protocol to ensure that quixaba seed powder remains homogenous and bioactive when incorporated into liquid shakes and suspensions. 3. Conducting iterative bioavailability trials to determine the optimal ratio of seed extract to powder in different pharmaceutical forms to ensure consistent glucose regulation effectiveness.
Are you eligible?
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
